Table 2.
Clinical features, angiographic findings, and medical treatment based on the definition of hyperuricemia in coronary artery disease patients.
| Baseline characteristics | Normouricemic patients (n = 486) | Hyperuricemic patients (n = 285) | P |
|---|---|---|---|
| Clinical characteristics | |||
| Unstable angina | 184 (37.9%) | 132 (46.3%) | 0.021 |
| NSTEMI | 75 (15.4%) | 34 (11.9%) | 0.178 |
| STEMI | 227 (46.7%) | 119 (41.7%) | 0.182 |
| Angiographic findings of vessel involvement | 0.036 | ||
| None | 41 (8.7%) | 16 (5.6%) | |
| Single vessel | 252 (53.3%) | 133 (46.8%) | |
| Double vessel | 93(19.7%) | 62 (21.8%) | |
| Triple vessel | 87 (18.4%) | 73 (25.7%) | |
| Left main disease | 29 (6.0%) | 23(8.1%) | 0.261 |
| Multi-vessel | 180 (38.1%) | 135 (47.5%) | 0.01 |
| Treatment | 0.421 | ||
| Drug | 111 (22.8%) | 56 (19.6%) | |
| Intervention | 324 (66.7%) | 203 (71.2%) | |
| Coronary artery bypass grafting | 51 (10.5%) | 26 (9.1%) | |
| Number of stents per patient: | 0.026 | ||
| 0 | 111 (26.4%) | 56 (22.5%) | |
| 1 | 184 (43.7%) | 109 (43.8%) | |
| 2 | 80 (19.0%) | 44 (17.7%) | |
| 3 | 33 (7.8%) | 18 (7.2%) | |
| 4~7 | 13 (3.1%) | 22 (8.8%) | |
Values are given as the number (%).
NSTEMI — non-ST-segment elevation myocardial infarction; STEMI — ST-segment elevation myocardial infarction